What is Neurocrine Biosciences's business sale proceeds?

Neurocrine Biosciences (NBIX) reported business sale proceeds of $63.20M in Q1 2026.

What does business sale proceeds mean?

Cash received from selling off parts of the business.

StatementCash Flow Statement

SectionInvesting

CategoryCapital Allocation

SignalContext dependent

VolatilityVolatile

First reportedQ1 2025

Last reportedQ1 2026May 5, 2026

An increase signals portfolio optimization or a strategic pivot, while a lack of proceeds suggests a stable, long-term asset base.

This metric represents the cash inflows received from the divestiture or sale of business segments, product lines, or su...

Occurs sporadically; peers often divest legacy segments to focus on high-margin innovation areas like continuous glucose monitoring or diagnostics.

Metric ID: proceeds_from_sale_of_business

2 periods

	Q1 '25	Q1 '26
Value	$0.00	$63.20M

Range$0.00 – $63.20M

What is Neurocrine Biosciences's business sale proceeds?: Neurocrine Biosciences (NBIX) reported business sale proceeds of $63.20M in Q1 2026.
What does business sale proceeds mean?: Cash received from selling off parts of the business.